Research Diagnosis Related Groups (DRG) level Readmission quality outcomes for Mount Sinai Beth Israel located at First Avenue And 16Th Street, New York, NY, 10003 & includes data from NPIs 1174689665, 1649415571, 1063657963
Dexur analyzed Q1 2019 (January to March 2019) Medicare claims data to benchmark 30 Day readmissions outcomes for Mount Sinai Beth Israel compared to state, national and top peer hospitals at the Diagnosis Related Group (DRG) level.
Total Hospitalizations (Jan 2019 to Mar 2019) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | New York Total Hospitalizations (Jan 2019 to Mar 2019) | New York Total Hospitalizations After Exclusion | New York Total Users | New York Readmission Rate(%) | National Total Hospitalizations ( Jan 2019 to Mar 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
All Inpatient | 811 | 743 | ||||||||||
Surgical | 173 | 165 | ||||||||||
Non Surgical | 638 | 578 | ||||||||||
Cardiovascular | 181 | 166 | ||||||||||
General Medicine | 155 | 133 | ||||||||||
Psychiatry & Mental Disorders | 114 | 112 | ||||||||||
Gastroenterology & Endocrinology | 77 | 72 | ||||||||||
Orthopedics | 69 | 64 | ||||||||||
Urology | 60 | 59 | ||||||||||
Pulmonology | 53 | 44 | ||||||||||
General Surgery | 44 | 39 | ||||||||||
Neurology | 29 | 26 | ||||||||||
Oncology & Hematology | 16 | 16 |
Total Hospitalizations (Jan 2019 to Mar 2019) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | New York Total Hospitalizations (Jan 2019 to Mar 2019) | New York Total Hospitalizations After Exclusion | New York Total Users | New York Readmission Rate(%) | National Total Hospitalizations ( Jan 2019 to Mar 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Acute Myocardial Infarction | ||||||||||||
DRG 280: ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 281: ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Percutaneous Cardiovascular Procedures With Coronary Artery/Stent | ||||||||||||
DRG 247: PERCUTANEOUS CARDIOVASCULAR PROCEDURES WITH DRUG-ELUTING STENT WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 246: PERCUTANEOUS CARDIOVASCULAR PROCEDURES WITH DRUG-ELUTING STENT WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) OR 4+ VESSELS OR STENTS | ||||||||||||
Heart Failure And Shock | ||||||||||||
DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Circulatory Disorders Except Ami With Cardiac Catheterization | ||||||||||||
Cardiac Arrhythmia And Conduction Disorders | ||||||||||||
Other Vascular Procedures | ||||||||||||
Other Major Cardiovascular Procedures |
Total Hospitalizations (Jan 2019 to Mar 2019) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | New York Total Hospitalizations (Jan 2019 to Mar 2019) | New York Total Hospitalizations After Exclusion | New York Total Users | New York Readmission Rate(%) | National Total Hospitalizations ( Jan 2019 to Mar 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Septicemia Or Severe Sepsis | ||||||||||||
DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Nutritional And Miscellaneous Metabolic Disorders | ||||||||||||
DRG 640: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) |
Total Hospitalizations (Jan 2019 to Mar 2019) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | New York Total Hospitalizations (Jan 2019 to Mar 2019) | New York Total Hospitalizations After Exclusion | New York Total Users | New York Readmission Rate(%) | National Total Hospitalizations ( Jan 2019 to Mar 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Psychoses | ||||||||||||
DRG 885: PSYCHOSES | ||||||||||||
Alcohol/Drug Abuse Or Dependence | ||||||||||||
DRG 897: ALCOHOL, DRUG ABUSE OR DEPENDENCE WITHOUT REHABILITATION THERAPY WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) |
Total Hospitalizations (Jan 2019 to Mar 2019) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | New York Total Hospitalizations (Jan 2019 to Mar 2019) | New York Total Hospitalizations After Exclusion | New York Total Users | New York Readmission Rate(%) | National Total Hospitalizations ( Jan 2019 to Mar 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Esophagitis, Gastroenteritis And Miscellaneous Digestive Disorders | ||||||||||||
DRG 392: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
G.I.Hemorrhage | ||||||||||||
DRG 377: G.I. HEMORRHAGE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Diabetes |
Total Hospitalizations (Jan 2019 to Mar 2019) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | New York Total Hospitalizations (Jan 2019 to Mar 2019) | New York Total Hospitalizations After Exclusion | New York Total Users | New York Readmission Rate(%) | National Total Hospitalizations ( Jan 2019 to Mar 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Major Hip And Knee Joint Replacement Or Reattachment Of Lower Extremity | ||||||||||||
DRG 470: MAJOR JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) |
Total Hospitalizations (Jan 2019 to Mar 2019) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | New York Total Hospitalizations (Jan 2019 to Mar 2019) | New York Total Hospitalizations After Exclusion | New York Total Users | New York Readmission Rate(%) | National Total Hospitalizations ( Jan 2019 to Mar 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Renal Failure | ||||||||||||
DRG 682: RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Kidney And Urinary Tract Infections |
Total Hospitalizations (Jan 2019 to Mar 2019) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | New York Total Hospitalizations (Jan 2019 to Mar 2019) | New York Total Hospitalizations After Exclusion | New York Total Users | New York Readmission Rate(%) | National Total Hospitalizations ( Jan 2019 to Mar 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Simple Pneumonia And Pleurisy |
Total Hospitalizations (Jan 2019 to Mar 2019) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | New York Total Hospitalizations (Jan 2019 to Mar 2019) | New York Total Hospitalizations After Exclusion | New York Total Users | New York Readmission Rate(%) | National Total Hospitalizations ( Jan 2019 to Mar 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Degenerative Nervous System Disorders |